KoBioLabs Inc
KOSDAQ:348150
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
KoBioLabs Inc
KOSDAQ:348150
|
KR |
|
Capital & Regional PLC
F:XC2R
|
UK |
|
P
|
Prisma Properties AB
F:V7D
|
SE |
|
C
|
ConectiSys Corp
OTC:CONC
|
US |
|
T
|
Tanke Inc
OTC:TNKE
|
US |
|
THC Therapeutics Inc
OTC:THCT
|
US |
|
C
|
Capital Point Ltd
TASE:CPTP
|
IL |
|
C
|
Chieftek Precision Co Ltd
TWSE:1597
|
TW |
|
X
|
X20 JSC
VN:X20
|
VN |
|
S
|
Sterling Consolidated Corp
OTC:STCC
|
US |
|
Contextlogic Inc
OTC:LOGC
|
US |
|
Alterola Biotech Inc
OTC:ABTI
|
US |
|
O
|
Orbis Se
XHAM:OBS
|
DE |
|
Nevada Copper Corp
F:ZYTA
|
CA |
|
D
|
DB Finance No.12 Special Purpose Acquisition Co Ltd
KOSDAQ:477760
|
KR |
|
M
|
Medical Facilities Corp
TSX:DR
|
CA |
|
Waseco Resources Inc
XTSX:WRI
|
CA |
|
I
|
International Metals Mining Corp
F:C2Y
|
CA |
|
Destiny Media Technologies Inc
F:DME1
|
CA |
|
Macro Metals Ltd
ASX:M4M
|
AU |
|
E
|
Eehwa Construction
KOSDAQ:001840
|
KR |
|
Members Co Ltd
TSE:2130
|
JP |
|
L
|
Liaoning Dingjide Petrochemical Co Ltd
SSE:603255
|
CN |
Bankruptcy Probability
KoBioLabs Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
KoBioLabs Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
K
|
KoBioLabs Inc
KOSDAQ:348150
|
60.1B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
468.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
181.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
57.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
KoBioLabs Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, KoBioLabs Inc has total debt of 15.6B KRW. This includes both short-term (9.4B KRW) and long-term (6.2B KRW) debt.
You can find a full breakdown on its Balance Sheet.
